Opening of Bids - Liberty Tower TIF Project Proj No. 123-054 -Trisco System, Inc.

Home Browse Search

8 Anti-Drug Policy Trisco Systems, Inc. shall require all employees, contracted employers, and contractors to follow all procedures, techniques, and methods outlined in 49 CFR Part 40, Part 382, and any applicable DOT agency regulation as of compliance date January 1, 1996 (382.115), as well as those outlined in this document. This written policy shall contain: Methods and procedures for compliance with all the requirements outlined in 49 CFR Part 40, Part 382, and any applicable DOT agency regulation; The name and address of the DAPM (Drug Abuse Program Manager) is found in Appendix A. The name and address of each laboratory that analyzed the specimens collected for drug testing. The name and address of Trisco System Inc.’s Medical Review Officer; and Procedures for notifying employees of the coverage and provisions of the policy. A contracted employer or a contractor shall allow access to property and records by the Company for the purpose of monitoring compliance with the requirements of this policy. Drug Testing Procedures If you have been selected for drug testing, the collection of your urine will be at a designated collection site and forwarded by them to a laboratory certified by the Department of Health and Human Services (DHHS). The procedures followed at the collection site should allow for individual privacy unless there is reason to believe that a particular individual may alter or substitute the urine specimen to be provided. The collection site person will take precautions to ensure that your specimen is not adulterated or diluted during the collection procedure. In addition, your specimen collection must follow strict chain of custody and security procedures. Responsibility for collection of your urine is solely that of the collection site facility. After the laboratory analysis, the results will be forwarded to the Medical Review Officer. The Medical Review Officer shall review and interpret any positive test results to determine if there is an alternative medical explanation for the confirmed positive test result. Prior to making a final decision to verify a positive test result to Trisco management, the Medical Review Officer will contact the employee at which time the employee will have an opportunity to discuss the test results with the Medical Review Officer and submit medical documentation of legally prescribed medications. Drug testing will be performed for any substance specified on Schedules I or II of the Controlled Substances Act, 21 U.S.C. 801.812 (1981 & 1987 Cum. P.P.) Including: marijuana, amphetamines, cocaine, opiates, phencyclidine, barbiturates, benzodiazepines, propoxyphene, and methadone. Screen and confirmation levels are found in Appendix B.